ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 240 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2023. The put-call ratio across all filers is 2.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,559,048 | +12.0% | 2,401,754 | +7.4% | 0.22% | +20.1% |
| Q2 2023 | $28,175,011 | +47.6% | 2,236,112 | +52.9% | 0.18% | +32.6% |
| Q1 2023 | $19,088,078 | -75.4% | 1,462,688 | -71.0% | 0.14% | -74.1% |
| Q4 2015 | $77,494,000 | +7.7% | 5,038,619 | -13.2% | 0.52% | +2.4% |
| Q3 2015 | $71,973,000 | -8.0% | 5,804,292 | +1.4% | 0.51% | +6.9% |
| Q2 2015 | $78,272,000 | +24.3% | 5,721,602 | +8.7% | 0.48% | +31.4% |
| Q1 2015 | $62,959,000 | -14.5% | 5,264,105 | -8.7% | 0.36% | -16.2% |
| Q4 2014 | $73,661,000 | -10.3% | 5,768,313 | -5.8% | 0.43% | -13.7% |
| Q3 2014 | $82,158,000 | +33.5% | 6,124,374 | +59.8% | 0.50% | +37.2% |
| Q2 2014 | $61,528,000 | -12.5% | 3,833,513 | -1.7% | 0.37% | -13.1% |
| Q1 2014 | $70,307,000 | +29.1% | 3,899,468 | +10.7% | 0.42% | +31.2% |
| Q4 2013 | $54,476,000 | +57.7% | 3,523,698 | +51.7% | 0.32% | +45.2% |
| Q3 2013 | $34,541,000 | – | 2,322,868 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |